Editas stock falls on a decision to seek a partner for its lead gene-therapy candidate, reni-cell, for SCD and TDT and focus ...

Oppenheimer analyst Jay Olson maintained a Hold rating on Editas Medicine (EDIT – Research Report) today and set a price target of ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Editas Medicine (EDIT – Research Report). The ...

AvenCell Therapeutics announced that it raised $115 million in a Series B round. The company is developing CAR-T therapies ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Ipsen has reported strong Q3 2024 results, with sales reaching 837 million euros ($884 million), an 8.6% year-on-year ...

CEST Biocartis announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting Mechelen, Belgium, 23 October 2024 ...

United Statescategory Phoenix officers put on leave in probe of violent arrest of disabled Black man 1:36 AM UTC Businesscategory US fines American Airlines record $50 million over treatment of ...

Fast bowler Rosemary Mair and offspinner Leigh Kasperek are out from the squad that won them their maiden T20 World Cup ...

The strategic shift will allow the firm to focus on advancing a newly announced in vivo gene-editing therapy candidate that's in preclinical development.

Phuket Immigration officers charged the employer of a Sri Lankan man for illegal employment at a construction site in Wichit. The Sri Lankan national, identified by police as K. Piyaralala, was ...